DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Bristol-Myers-Squibb.
Study to evaluate a single dose of apixaban in pediatric participants at risk for a thrombotic disorder (NCT01707394).
2012 . Accessed October 2021 at:
https://clinicaltrials.gov/ct2/show/NCT01707394
Access:
We do not assume any responsibility for the contents of the web pages of other providers.